Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Qvin
AddedMar 17, 2024
UpdatedJul 16, 2026
Qvin

Qvin

Series A

Qvin: Pioneering menstrual blood tests for women's health insights.

HQ
Menlo Park, CA, US
Founded
2014
Accelerator
Y Combinator logoY CombinatorW16
Overview
Compare
Fundraising
Employees
Website

Founded in 2014 by Dr. Sara Naseri and Søren Therkelsen, Qvin aims to revolutionize women's healthcare by utilizing menstrual blood for critical health diagnostics. Their core mission is to empower women by providing an alternative to traditional lab tests, enabling them to access personalized health data from the comfort of their homes. Qvin's innovative service transforms menstrual blood into lab reports, offering a needle-free, convenient method for women to monitor their health.

Qvin has garnered attention for its groundbreaking approach, attracting notable investors and healthcare professionals. The company has achieved significant milestones, including patenting its unique technology and gaining recognition in the healthcare industry. By providing an accessible and non-invasive diagnostic tool, Qvin has made a substantial impact on women's health, challenging the status quo and advocating for greater autonomy and prioritization of women's healthcare needs.

Qvin - Similar Companies

Inito logo

Inito

inito.com

BloodQ logo

BloodQ

bloodq.com

Neodocs logo

Neodocs

neodocs.in

Probius logo

Probius

probius.bio

NextGen Jane logo

NextGen Jane

nextgenjane.com

Proov logo

Proov

proovtest.com

Vena Vitals logo

Vena Vitals

venavitals.com

Instalab logo

Instalab

instalab.com

DotLab logo

DotLab

dotlab.com

Q Bio logo

Q Bio

q.bio

Pnoē logo

Pnoē

pnoe.com

Hera Biotech logo

Hera Biotech

herabiotech.com

DaVinci Wearables logo

DaVinci Wearables

adyn logo

adyn

Qidni Labs logo

Qidni Labs

Qvin - Quick Facts

Who are Qvin's competitors?

Companies similar to Qvin include Inito, BloodQ, Neodocs and Probius.

When was Qvin founded?

Qvin was founded in 2014.

Where is Qvin's headquarters located?

Qvin's headquarters is located in Menlo Park, CA, US.

When was Qvin's last funding round?

Qvin's most recent funding round was for $12.3M (USD) in March 2021.

How much has Qvin raised to-date?

As of Mar 1, 2021, Qvin has raised a total of $12.4M (USD).

How many employees does Qvin have?

Qvin has 25 employees as of Feb 5, 2024.

Qvin - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
Customer
  • Consumers
Main Product
  • Health Diagnostics
Tags
  • Data Information
  • FemTech
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities